Together, these findings indicate that systemic p38 blockade and tumor-specific inactivation of p38α markedly reduce the generation and/or expansion of pro-tumor myeloid cell populations, while positively regulating factors promoting T cell mediated immunity. Here, MAPK14 is linked to neoplasm.